| abstract |
This invention provides a compound represented by formula (1) or pharmaceutical acceptable salt thereof, which is useful as a VAP-1 inhibitor, pharmaceutical compositions, prophylactic or therapeutic medicine of VAP-1 related disorders such as macular edema and increase in vascular permeability and the like, R1-NH-X-Y-Z (I) (wherein, each symbol has the same meaning as it defined in the specification). |